Sector
PharmaceuticalsOpen
₹57.19Prev. Close
₹57.19Turnover(Lac.)
₹6.66Day's High
₹60.88Day's Low
₹55.3552 Week's High
₹87.4652 Week's Low
₹31.9Book Value
₹18.08Face Value
₹10Mkt Cap (₹ Cr.)
196.51P/E
0EPS
0Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 35.27 | 21.44 | 10.27 | 10.27 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 35.79 | 0.98 | -1.6 | -1.74 |
Net Worth | 71.06 | 22.42 | 8.67 | 8.53 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 3.93 | 8.55 | 0 | 0.44 |
yoy growth (%) | -53.93 | 0 | -100 | -62.64 |
Raw materials | -3.57 | -8.15 | 0 | -0.49 |
As % of sales | 90.66 | 95.41 | 0 | 110.08 |
Employee costs | -0.04 | -0.04 | -0.02 | -0.06 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 0.14 | 0.08 | -0.37 | -0.36 |
Depreciation | 0 | -0.04 | -0.03 | 0 |
Tax paid | 0 | 0 | 0.4 | -0.01 |
Working capital | -0.05 | -0.09 | -0.16 | -0.62 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -53.93 | 0 | -100 | -62.64 |
Op profit growth | 28.21 | -131.86 | -13.1 | 12.42 |
EBIT growth | 61.7 | -123.62 | 1.95 | -7.53 |
Net profit growth | 55.54 | 178.26 | -108.69 | -451.66 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 |
---|---|---|---|
Gross Sales | 19.45 | 15.11 | 0 |
Excise Duty | 0 | 0 | 0 |
Net Sales | 19.45 | 15.11 | 0 |
Other Operating Income | 0 | 0 | 0 |
Other Income | 0.1 | 0.88 | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.65 | 92.31 | 3,95,326.43 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,537.95 | 78.57 | 1,73,562.03 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,498.35 | 24.58 | 1,21,022.9 | 1,485.4 | 1.07 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,312.75 | 20.48 | 1,09,550.72 | 1,200.7 | 0.61 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,226.65 | 57.31 | 1,09,199.59 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director
Venu Madhava Kaparthy
Executive Director
Mini Manikantan
Independent Non Exe. Director
P N Vijay
Independent Non Exe. Director
Methuku Nagesh
Non Executive Director
Shreedhara Shetty
Chairman (Non-Executive)
Shankarappa Nagaraja Vinaya Babu
Independent Non Exe. Director
M Sudheer Anand
Company Sec. & Compli. Officer
Prasanna Subramanya Bhat.
4-4-211/212/3 1st Floor,
Inderbagh Sulthan Bazar,
Telangana - 500095
Tel: 91-40-66669809
Website: http://www.pharmaids.com
Email: compliance@pharmaids.com
12-10-167,
Bharath Nagar,
Hyderbad - 500018
Tel: 91-040-23818475/76/2
Website: www.vccilindia.com
Email: info@vccilindia.com
Summary
Pharmaids Pharmaceuticals Limited, incorporated in March, 1989 at Hyderabad, Telangana are the suppliers of Quality Grade range of speciality chemicals, skin care, hospital care and generic products i...
Read More
Reports by Pharmaids Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.